RxDoctor Payments Data

Timothy Taylor

Primary Care · Valdosta, GANPI 1356847743

Payments from drug & device makers

$818in general payments, 2019–2025

Across 49 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$318
  • Lilly USA, LLC$145
  • Novo Nordisk$65
  • Takeda Pharmaceuticals U.S.A., Inc.$54
  • Dexcom, Inc.$52
  • Antares Pharma, Inc.$50
  • plus $134 from 5 others

What the payments were for

  • Food & beverage$818100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$818 in reported general payments places this provider in the 60th percentile of 235 primary care providers in Georgia.

See all primary care providers in Georgia

Medicare billing

Part B allowed, 2024
$70,460
Medicare patients
310
Services billed
2,937

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$56,620
MounjaroTirzepatide39$48,317
JardianceEmpagliflozin30$27,491
EliquisApixaban12$11,579
JanuviaSitagliptin Phosphate11$7,522
SymbicortBudesonide/Formoterol Fumarate12$2,597
Levothyroxine Sodium101$920
Atorvastatin Calcium103$811
Potassium Chloride42$758
Amlodipine Besylate99$720
Omeprazole44$632
Losartan Potassium61$603
Pantoprazole Sodium48$594
Metoprolol Succinate46$588
Lisinopril58$574

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$65$56,62058 claims
Lilly USA, LLCMounjaro$145$48,31739 claims
PfizerEliquis$46$11,57912 claims
AstraZenecaSymbicort$318$2,59712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 235 primary care providers in Georgia.

Other primary care in Valdosta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →